News
FDA issues update on breast implant-associated ALCL
The US Food and Drug Administration (FDA) has issued an update on breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL). The agency...
News
AYAs struggle socially in early years after cancer diagnosis
A new study indicates that adolescent and young adult (AYA) cancer survivors continue to face social difficulties for more than 2 years after...
News
Study supports use of rivaroxaban to prevent VTE recurrence
WASHINGTON, DC—Results of the EINSTEIN CHOICE study suggest rivaroxaban is more effective than, and just as safe as, aspirin for long-term...
News
Proteins may be therapeutic targets for TKI-resistant CML, ALL
Researchers say they have identified 2 signaling proteins that enable resistance to tyrosine kinase inhibitors (TKIs) and could be therapeutic...
News
Allo-HSCT cures adult with congenital dyserythropoietic anemia
Physicians have reported what they believe is the first case of an allogeneic hematopoietic stem cell transplant (allo-HSCT) curing an adult with...
News
New insight into high-hyperdiploid ALL
New research appears to explain how 10q21.2 influences the risk of high-hyperdiploid acute lymphoblastic leukemia (HD-ALL). Previous research...
News
Apixaban bests warfarin in real-world analysis
WASHINGTON, DC—An analysis of real-world data suggests elderly patients with non-valvular atrial fibrillation (NVAF) have a lower risk of stroke...
News
Major bleeding lower with dabigatran than warfarin
WASHINGTON, DC—Results from the RE-CIRCUIT trial suggest that uninterrupted dabigatran poses a lower risk of major bleeding than uninterrupted...
News
Drugs demonstrate similar safety profile in ACS trial
WASHINGTON, DC—Results of a phase 2 trial suggest rivaroxaban and aspirin have similar safety profiles in patients with acute coronary syndrome (...
News
PE patients rarely receive CDT or ST, study shows
WASHINGTON, DC—New research suggests US patients with pulmonary embolism (PE) rarely receive catheter-directed thrombolysis (CDT) or systemic...
News
Therapy can produce durable CRs in NHL
When given after low-dose chemotherapy, an anti-CD19 chimeric antigen receptor (CAR) T-cell therapy can produce durable complete responses (CRs)...
News
ADCs could treat myeloma, other malignancies
A class of antibody-drug conjugates (ADCs) have shown promise for treating hematologic and solid tumor malignancies, according to research...
News
Funders could do more to reduce research waste, team says
A study published in The Lancet suggests agencies that distribute public funds for research could do more to reduce waste. Investigators...
News
Computerized systems reduce risk of VTE, analysis suggests
The use of computerized clinical decision support systems can reduce the risk of venous thromboembolism (VTE) among surgical patients, according...
News
Team develops paper-based test for blood typing
Researchers say they have created a paper-based assay that provides “rapid and reliable” blood typing. The team used this test to analyze 3550...